Filters

Tip: Use OR to search multiple keywords (example: breast OR brain OR prostate OR imaging).
Funding Type
Application Due Date
Enter dates in the format YYYY-MM-DD (ex. 2025-03-01)

DoW Breast Cancer, Transformative Breast Cancer Consortium

Organization
Dept. of the Army -- USAMRAA
Type
DOW
website
Application Due Date
07-08-2026

Summary: The fiscal year 2026 (FY26) Breast Cancer Research Program (BCRP) Transformative Breast Cancer Consortium Development Award provides successful applicants the time and resources needed to bring investigators and breast cancer consumer advocates together to establish a consortium framework and conduct preliminary research in support of an application to a future, full BCRP Transformative Breast Cancer Consortium Award (pending availability of funds). All applications must address at least one of the FY26 BCRP overarching challenges or provide adequate justification for exception.

Distinctive Features:

  • This is a development award and is a separate award mechanism from the full FY26 BCRP Transformative Breast Cancer Consortium Award (HT942526BCRPTBCCA). For FY26, investigators may be named as Consortium Director on an application submitted to either (but not both) of these award mechanisms.
  • Breast cancer consumer advocates must be active participants in the development and execution of the FY26 BCRP TBCCDA.